OXYBUTYNIN CHLORIDE
NDC 64980-734, OXYBUTYNIN CHLORIDE, tablet, from RISING PHARMA HOLDINGS, INC..
- Product NDC
- 64980-734
- Status
- Listed
- Labeler
- RISING PHARMA HOLDINGS, INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209025
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE2.5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-734-01 | 64980073401 | 100 TABLET in 1 BOTTLE (64980-734-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9578b6b8-5b9d-4263-9142-39b2c7216b85
Use it
Look up 64980-734 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.